Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring.

Item

http://www.wikidata.org/entity/Q41723791

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Pediatric vancomycin dosing: T ...... f therapeutic drug monitoring.

@en

type

Item

label

Pediatric vancomycin dosing: T ...... f therapeutic drug monitoring.

@en

prefLabel

Pediatric vancomycin dosing: T ...... f therapeutic drug monitoring.

@en

P1476

Pediatric vancomycin dosing: T ...... of therapeutic drug monitoring

@en

P2093

Emily A Thorell

http://www.w3.org/2001/XMLSchema#string

Ernest K Korgenski

http://www.w3.org/2001/XMLSchema#string

Jonathan E Constance

http://www.w3.org/2001/XMLSchema#string

Michael G Spigarelli

http://www.w3.org/2001/XMLSchema#string

Sarah C Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.

Vancomycin ototoxicity: a reevaluation in an era of increasing doses.

Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Trends in invasive methicillin-resistant Staphylococcus aureus infections.

A prospective study of adverse reactions associated with vancomycin therapy.

Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.

P304

212-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.402

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chris Stockmann

Catherine M Sherwin

Alfred H Balch

P577

2014-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25264036

http://www.w3.org/2001/XMLSchema#string

P932

5641452

http://www.w3.org/2001/XMLSchema#string